MADISEN MCKELL: Open Payments
NPI 1508592767 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 53 payments from 17 companies in 2025. Trend: 2023 $492 · 2024 $568 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $352 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $123 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Novo Nordisk Inc | 2 | $42 |
| PFIZER INC. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Corium, LLC | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: QULIPTA, CAPLYTA, VRAYLAR, UBRELVY, REXULTI, PREVNAR 20, AIRSUPRA, SPRAVATO.
Industry payments across UT — which companies pay providers there.
